Table 3

Correlation of clinical parameters with risk groups in the test cohort (n = 181)

CharacteristicLow risk, %High risk, %P
Age, 65 y or older 30 23 .692 
Albumin, less than 35 g/L 17 32 .163 
β2-microglobulin 
    Less than 297.5 nM 57 32 .005 
    297.5 nM to less than 467.5 nM 23 18  
    467.5 nM or more 19 50  
C-reactive protein, 4 mg/L or above 44 59 .271 
LDH, 190 IU/L or above 18 59 < .001 
Cytogenetic abnormalities 27 77 < .001 
GEP-based translocations 
    CCND1 14 < .001 
    MMSET 12 23  
    MAF/MAFB 36  
    No spike 67 41  
CharacteristicLow risk, %High risk, %P
Age, 65 y or older 30 23 .692 
Albumin, less than 35 g/L 17 32 .163 
β2-microglobulin 
    Less than 297.5 nM 57 32 .005 
    297.5 nM to less than 467.5 nM 23 18  
    467.5 nM or more 19 50  
C-reactive protein, 4 mg/L or above 44 59 .271 
LDH, 190 IU/L or above 18 59 < .001 
Cytogenetic abnormalities 27 77 < .001 
GEP-based translocations 
    CCND1 14 < .001 
    MMSET 12 23  
    MAF/MAFB 36  
    No spike 67 41  
Close Modal

or Create an Account

Close Modal
Close Modal